How severe is CVE-2023-33364?

CVE-2023-33364 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2023-33364 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (72nd percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-33364?

CVE-2023-33364 affects Supremainc Biostar 2. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-33364?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2023-33364 published?

CVE-2023-33364 was published on 2023-08-03 and last updated on 2026-06-17.

CVE-2023-33364

CVE-2023-33364 is a high-severity vulnerability in Supremainc Biostar 2 with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Severity: High (CVSS 3.x base score 8.8)
EPSS exploit prediction: 2% (72nd percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-78
Affected product: Supremainc Biostar 2
Published: 2023-08-03
Last modified: 2026-06-17

Description

An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.

Frequently asked questions

What is CVE-2023-33364?: An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.
How severe is CVE-2023-33364?: CVE-2023-33364 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-33364 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (72nd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-33364?: CVE-2023-33364 affects Supremainc Biostar 2. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-33364?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-33364 published?: CVE-2023-33364 was published on 2023-08-03 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:supremainc:biostar_2:*:*:*:*:*:*:*:*

More vulnerabilities in Supremainc Biostar 2

CVE-2023-33366 — High (CVSS 8.8): A SQL injection vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows authenticated users to inject…
CVE-2023-31923 — High (CVSS 8.8): Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an…
CVE-2022-38351 — High (CVSS 8.8): A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System…
CVE-2023-33365 — High (CVSS 7.5): A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to…
CVE-2023-33363 — High (CVSS 7.5): An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to…
CVE-2020-15050 — High (CVSS 7.5): An issue was discovered in the Video Extension in Suprema BioStar 2 before 2.8.2. Remote attackers can read arbitrary…

All CVEs affecting Supremainc Biostar 2 →

Other CWE-78 (OS Command Injection) vulnerabilities

CVE-2026-56004 — Critical (CVSS 10.0): A shellcode injection in the mercurial handler of the obs tar_scm source service before version 0.12.4 could be used by…
CVE-2026-56415 — Critical (CVSS 10.0): Storage Concentrator (SC & SCVM) contains a command injection vulnerability within the debug.pl script that is…
CVE-2026-56413 — Critical (CVSS 10.0): Storage Concentrator (SC & SCVM) contains a command injection vulnerability in the ms_service.pl service, which listens…
CVE-2026-49869 — Critical (CVSS 10.0): Kestra is an open-source, event-driven orchestration platform. Prior to 1.0.45 and 1.3.21, AuthenticationFilter in…
CVE-2026-49261 — Critical (CVSS 10.0): MariaDB server is a community developed fork of MySQL server. Versions 10.6.1 through 10.6.26, 10.11.1 through…
CVE-2026-10520 — Critical (CVSS 10.0): An OS Command Injection vulnerability in Ivanti Sentry before the R10.5.2, R10.6.2 and R10.7.1 versions allows a…

Browse all CWE-78 (OS Command Injection) vulnerabilities →